• Protease Inhibitor Cocktail for OXPHOS Assays

  2026-08-12

  The Protease Inhibitor Cocktail helps preserve protein-level evidence in OXPHOS and cancer-metabolism workflows. This guide connects EDTA-free protease control with dual-genome assay design, interpretation, and practical extraction decisions.

• Preserving DFCP1–ATGL Biology in Lysates

  2026-08-11

  A translational guide to preserving DFCP1–ATGL complexes and lipid-droplet biology during extraction, with practical strategies for using a broad-spectrum Protease Inhibitor Cocktail without compromising downstream assays.

• (S)-(+)-Methoprene as a JH Signaling Probe

  2026-08-11

  (S)-(+)-Methoprene is a juvenile hormone analog that helps separate upstream hormone biosynthesis from downstream receptor signaling. This guide translates miRNA–mRNA findings in locust corpora allata into practical assay designs for developmental, reproductive, and comparative receptor studies.

• Fluorescein TSA Fluorescence System Kit Workflow

  2026-08-10

  The Fluorescein TSA Fluorescence System Kit brings high-sensitivity tyramide signal amplification to IHC, ICC, and ISH workflows where conventional fluorescence is too faint. This practical guide connects the kit to NET-DNA–ILC3 biology, showing how to improve spatial detection while controlling background, deposition, and photobleaching.

• ssBIR and DNA Damage Amplification in Mouse Oocytes

  2026-08-09

  The reference study identifies short-scale break-induced replication (ssBIR) in fully grown mouse oocytes and shows that DNA double-strand breaks can amplify through Rad51-dependent repair and DNA synthesis. Its EdU-based imaging strategy, combined with replication and checkpoint inhibitors, provides a practical framework for distinguishing localized repair synthesis from broader genome-damage responses.

• Protease Inhibitor Cocktail for Plant Protein Studies

  2026-08-08

  Protect fragile plant proteins during extraction, immunoblotting, co-immunoprecipitation, and kinase assays with a broad-spectrum, EDTA-free formulation. This workflow connects protein preservation to the NSP2–MYB40 symbiosis model, helping researchers distinguish biological regulation from extraction-induced protein degradation.

• Caffeine: Mechanism and Research Use

  2026-08-07

  Caffeine, also known as 1,3,7-trimethylpurine-2,6-dione, is a purine alkaloid studied for adenosine receptor antagonism, cancer cell line inhibition, and energy metabolism modulation. Product-dossier findings support model-specific use in sarcoma assays and diet-induced obesity mouse studies, but they do not establish clinical efficacy.

• Q-VD(OMe)-OPh: Precision Caspase Inhibition in Apoptosis Ass

  2026-08-07

  Q-VD(OMe)-OPh sets a new standard for broad-spectrum, non-toxic caspase inhibition, enabling highly reproducible apoptosis research. Its superior specificity, low cytotoxicity, and versatile solubility profile power advanced workflows across cancer, neuroprotection, and cell differentiation studies.

• Toremifene and the Evolution of Endocrine Therapy in Breast

  2026-08-06

  This review dissects 20 years of clinical and translational data on toremifene, highlighting its role as a selective estrogen receptor modulator (SERM) in breast cancer management. The paper contextualizes advances in endocrine therapy, biomarker-driven personalization, and the nuanced comparison of SERMs with steroidal aromatase inhibitors for hormone-responsive malignancies.

• DiscoveryProbe™ Natural Product Library Plus: Deep Screening

  2026-08-06

  Explore the DiscoveryProbe Natural Product Library Plus for advanced natural product screening. This article reveals how rigorous compound profiling transforms drug discovery beyond standard HTS, with actionable insights from recent anti-parasitic research.

• Cisapride (R 51619): Reliable Cardiac Electrophysiology Rese

  2026-08-05

  This article delivers practical, scenario-driven insights for cardiac electrophysiology research using Cisapride (SKU B1198). Drawing on peer-reviewed data and APExBIO’s rigorous quality controls, we address common lab challenges in phenotypic screening, protocol design, assay interpretation, and vendor selection. The content is tailored for bench scientists aiming for reproducible, high-content cardiotoxicity and 5-HT4 signaling studies.

• LGK-974: PORCN Inhibitor Workflows for Wnt-Driven Cancer Mod

  2026-08-05

  LGK-974 empowers researchers to dissect and inhibit the Wnt signaling pathway with nanomolar precision, making it indispensable for modeling Wnt-driven cancer and exploring pathway-targeted interventions. This article translates the latest mechanistic insights and experimental protocols into actionable guidance, unlocking robust, reproducible results in pancreatic and other Wnt-dependent cancer assays.

• Boc-D-FMK: Pan-Caspase Inhibitor for Advanced Apoptosis Rese

  2026-08-04

  Boc-D-FMK, a potent pan-caspase inhibitor from APExBIO, enables precise and reproducible inhibition of apoptotic and inflammatory pathways in cell and animal models. This article details actionable workflows, protocol enhancements, and troubleshooting strategies to maximize experimental success in apoptosis and inflammation research.

• Hypoxia-Driven EGFR Inhibitor Resistance in NSCLC via FGFR1/

  2026-08-04

  Lu et al. reveal that moderate hypoxia induces resistance to EGFR tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC) cells through upregulation of FGFR1 and activation of the MAPK pathway. This mechanistic insight suggests that dual targeting of EGFR and FGFR1 or MEK may improve therapeutic outcomes and overcome hypoxia-mediated drug resistance.

• Mubritinib Targets OXPHOS Dependency in Acute Myeloid Leukem

  2026-08-03

  Baccelli et al. (2019) identified Mubritinib (TAK 165) as a selective inhibitor of mitochondrial complex I, demonstrating pronounced cytotoxicity against chemotherapy-resistant acute myeloid leukemia (AML) subtypes dependent on oxidative phosphorylation. This mechanistic insight broadens the therapeutic landscape for poor-prognosis AML and offers new direction for metabolic targeting strategies.

16825 records 1/1122 page Next 12345 下5页 Last page